41 – 50 of 125
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Decreased HLA-DQ expression on peripheral blood cells in children with varying number of beta cell autoantibodies
(
- Contribution to journal › Article
-
Mark
Motifs of Three HLA-DQ Amino Acid Residues (α44, β57, β135) Capture Full Association With the Risk of Type 1 Diabetes in DQ2 and DQ8 Children
(
- Contribution to journal › Article
-
Mark
Screening for autoantibody targets in post-vaccination narcolepsy using proteome arrays
(
- Contribution to journal › Article
-
Mark
Distinct growth phases in early life associated with the risk of type 1 diabetes : The teddy study
(
- Contribution to journal › Article
- 2019
-
Mark
Who is enrolling? The path to monitoring in type 1 diabetes trialnet’s pathway to prevention
(
- Contribution to journal › Article
-
Mark
HLA high-resolution typing by next-generation sequencing in Pandemrix-induced narcolepsy
(
- Contribution to journal › Article
-
Mark
Metabolite-related dietary patterns and the development of islet autoimmunity
(
- Contribution to journal › Article
-
Mark
Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials—GPPAD-02 study design and first results
(
- Contribution to journal › Article
-
Mark
Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk : The GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
(
- Contribution to journal › Article
-
Mark
Autoantibodies in Pandemrix®-induced narcolepsy : Nine candidate autoantigens fail the conformational autoantibody test
(
- Contribution to journal › Article